Matthew Eckler

Stock Analyst

(n/a)
# 4,424
Out of 4,433 analysts
4
Total ratings
n/a
Success rate
n/a
Average return

3 Stocks

Dynavax Technologies
Nov 6, 2018
Maintains: Outperform
Price Target: n/a
Current: $11.04
Upside: -
Inovio Pharmaceuticals
Oct 18, 2017
Initiates: Outperform
Price Target: $132
Current: $13.07
Upside: +909.95%
Abeona Therapeutics
Sep 15, 2017
Initiates: Outperform
Price Target: n/a
Current: $4.71
Upside: -